Blood test could guide use of anti-inflammatory drug celecoxib to reduce risk of colon cancer recurrence
A data analysis from a randomized clinical trial for stage 3 colon cancer patients by investigators at Dana-Farber Brigham ...
devdiscourse9h
Celecoxib Boosts Survival Odds for Colon Cancer Patients
Recent research indicates that colon cancer patients with circulating tumor DNA post-surgery may improve their survival likelihood with daily celecoxib use. Celecoxib, a COX-2 inhibitor, significantly ...
Health Rounds: Old anti-inflammatory may delay colon cancer recurrence
Patients with colon cancer who still have cancer cells in their blood after surgery may improve their survival odds with ...
Armed robbery in Revesby6d
Blood Test Guides Drug to Cut Colon Cancer Recurrence
The Alliance for Clinical Trials in Oncology today announced the results of a data analysis from a randomized phase III ...
EurekAlert!6d
Blood test from Alliance trial guides use of anti-inflammatory drug to lower colon cancer recurrence risk
The Alliance for Clinical Trials in Oncology today announced the results of a data analysis from a randomized phase III clinical trial involving patients with stage III colon cancer, which found that ...
FDA approves first new type of pain medication in 25 years
A new pain relief drug, suzetrigine, is a prescription pill that’s taken every 12 hours after a larger starter dose. It will ...
FDA approves suzetrigine, the first new painkiller since 1998
The Food and Drug Administration announced Thursday its approval of suzetrigine, the first new painkiller greenlit by the agency since 1998.
Medscape3d
Multifocal Fixed Drug Eruption Due to Celecoxib
[1] A case of this drug reaction from celecoxib is reported. A 61-year-old nonatopic woman presented with 15 round, red-brown, edematous, moderately itching patches. Their size varied from 2 to 10 ...